Study of cytokine gene expression in small cell samples: Use in induced sputum

Journal of Immunological Methods

Volumn 280, Issue 1-2, 2003, Pages 37-47

  Mamessier, E ^a   Boniface, S ^a   Dupuy, P ^b   Reynaud Gaubert, M ^a   Vervloet, D ^a   Magnan, A ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSERM   (France)

Author keywords

Airway inflammation; Cytokines; Induced sputum; mRNA; RT PCR

Indexed keywords

BETA ACTIN; CHLOROFORM; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; LYMPHOTOXIN; MESSENGER RNA; PHENOL; RNA;

AIRWAY; ARTICLE; CELL COUNT; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; SPUTUM EXAMINATION; SPUTUM SMEAR;

EID: 0142043426     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(03)00230-8     Document Type: Article

References (26)

1. Belda J., Leigh R., Parameswaran K., O'Byrne P.M., Sears M.R., Hargreave F.E. Induced sputum cell counts in healthy adults. American Journal of Respiratory and Critical Care Medicine. 161:2000;475-478.
2. Boniface S., Lorec A.M., Badier M., Vervloet D., Magnan A. Expectoration induite en allergologie: indications et techniques. Revue des Maladies Respiratoires. 19:2002;381-383.
3. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry. 162:1987;156-159.
4. Erin E.M., Barnes P.J., Hansel T.T. Optimizing sputum methodology. Clinical and Experimental Allergy. 32:2002;653-657.
5. Fahy J.V., Boushey H.A., Lazarus S.C., Manger E.A., Cherniack R.M., Chinchilli V.M., Sorkness C., Szelfer S. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. American Journal of Respiratory and Critical Care Medicine. 163:2001;1470-1475.
6. Fireman E., Greif J., Schwarz Y., Man A., Ganor E., Ribak Y., Lerman Y. Assessment of hazardous dust exposure by BAL and induced sputum. Chest. 115:1999;1720-1728.
7. Gelder C.M., Thomas P.S., Yates D.H., Adcock I.M., Morrison J.F., Barnes P.J. Cytokines expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction. Thorax. 50:1995;1033-1037.
8. Gibson P.G., Simpson J.L., Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest. 119:2001;1329-1336.
9. Grootendorst D.C., Sont J.K., Willems L.N.A., Kluin-Nelemans J.C., Van krieken J.H.J.M, Veselic-Charvat M., Sterk P.J. Comparison of inflammatory cell counts in asthma: induced sputum vs. bronchoalveolar lavage and bronchial biopsies. Clinical and Experimental Allergy. 27:1997;769-779.
10. Hamzaoui A., Ben Brahim M., Zhioua A., Ayed Kh. , Hamzaoui K. Inflammatory response in induced sputum mononuclear cells from patients with acute exacerbation of asthma. Mediators of Inflammation. 9:2000;147-153.
11. Holz O., Kips J., Magnussen H. Update on sputum methodology. European Respiratory Journal. 16:2002;355-359.
12. Jatakanon A., Lim S., Barnes P.J. Changes in sputum eosinophils predict loss of asthma control. American Journal of Respiratory and Critical Care Medicine. 161:2000;64-72.
13. Magnan A., Mély L., Camilla C.A., Badier M., Bongrand P., Vervloet D. Assessment of the TH1/TH2 paradigm in whole blood in atopy and Asthma: increased IFN-gamma-producing CD8+ T cells in asthma. American Journal of Respiratory and Critical Care Medicine. 161:2000;1790-1796.
14. Magnan A., Boniface S., Mély L., Romanet S., Mamessier E., Vervloet D. Cytokines, from atopy to asthma: the Th2 dogma revisited. Cellular and Molecular Biology. 47:2001;679-687.
15. Mannhalter C., Koizar D., Mitterbauer G. Evaluation of RNA isolation methods and reference genes for RT-PCR analyses of rare target RNA. Clinical Chemistry and Laboratory Medicine. 38(2):2000;171-177.
16. Muraille E. Revisiting the Th1/Th2 paradigm. Scandinavian Journal of Immunology. 47:1998;1-9.
17. Pizzichini E., Pizzichini M.M.M., Efthimiadis A., Hargreave F.E., Dolovich J. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. European Respiratory Journal. 9:1996;1174-1180.
18. Pizzichini E., Pizzichini M.M.M., Kidney J.C., Efthimiadis A., Hussack P., Popov T., Cox G., Dolovich J., O'Byrne P., Hargreave F.E. Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: inflammatory cells, lymphocyte subsets and soluble markers compared. European Respiratory Journal. 11:1998;828-834.
19. Revillard J.P. "Immunologie", "Cytokines et facteurs de croissance", De Boek and Larcier s.a., 3 ème edition. Chapitre. 8:1998;97-110.
20. Robinson D.S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A.M., Corrigan C., Durham S.R., Kay A.B. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. New England Journal of Medicine. 326:1992;298-304.
21. Salvi S.S., Babu K.S., Holgate S.T. Is asthma really due to a polarized T cell response toward a helper T cell type 2 phenotype? American Journal of Respiratory and Critical Care Medicine. 164(8 Pt 1):2001;1343-1346.
22. Sambrook J., Russell D.W., Irwin N., Jansssen K.A. Molecular Cloning, A Laboratory Manual. 2001;Cold Spring Harbor Laboratory Press, New York.
23. Spanevello A., Confalonieri M., Sulotto F., Romano F., Balzano G., Migliori G.M., Bianchi A., Michetti G. Induced sputum cellularity. American Journal of Respiratory and Critical Care Medicine. 162:2000;1172-1174.
24. Tarodo de la Fuente P., Romagnoli M., Godard P., Bousquet J., Chanez P. Safety of inducing expectoration in patients with asthma of varying severity. American Journal of Critical Care Medicine. 157:1998;1127-1130.
25. Tournoy K.G. Is Th1 the solution for Th2 in asthma? Clinical and Experimental Allergy. 31:2002;17-29.
26. Walker Barry K. Detection and analysis of cytokine mRNA in tissues and cell lines. Journal of Immunological Methods. 212:1998;113-123.